Brief: Astrazeneca To Acquire Fusion To Accelerate The Development Of Next-Generation Radioconjugates To Treat Cancer

Fusion Co

19/03/2024 11:13

March 19 (Reuters) - Fusion Co Ltd  3977.SP :
    * ASTRAZENECA TO ACQUIRE FUSION TO ACCELERATE THE
DEVELOPMENT OF
NEXT-GENERATION RADIOCONJUGATES TO TREAT CANCER

Source text for Eikon:  ID:nBw3WmR2ga 
Further company coverage:  3977.SP 

 ((Reuters.Briefs@thomsonreuters.com;))